In this issue of
Clinics in Liver Disease, guest editor Dr. Vinod K. Rustgi brings his considerable expertise to the topic of
Current and Next Generation Therapeutics in Hepatology. Top experts in hepatology provide updates on the latest pharmaceuticals available as well as those in the pipeline for a wide range of liver diseases.
- Contains 11 relevant, practice-oriented topics including primer of CRISPR: gene therapy and molecular therapies; evolving treatments of cirrhosis; what is coming in the world of liver transplantation; weight loss drugs: current and future implications for liver disease; sensors and wearables in hepatology; and more
- Provides in-depth clinical reviews on current and next generation therapeutics in hepatology, offering actionable insights for clinical practice
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
Liver-Directed Molecular Therapies: Current and Upcoming Strategies
New Approaches to Alcohol-Associated Hepatitis
Therapies and Pipeline for Hepatitis B and Hepatitis D
Recent Advances in Primary Biliary Cholangitis Treatment
Current Status and Future Directions in the Pharmacologic Management of
Cirrhosis
Novel Therapeutics for Hepatocellular Carcinoma
Current Focus and Innovation in Liver Transplantation
Radiomics in Hepatology: Therapeutic Applications in Hepatocellular
Carcinoma
Current and Future Implications of Weight Loss Drugs on Liver Disease
Artificial Intelligence and Machine Learning Applications in Liver Disease
Pediatric Liver Diseases: Next-Generation Therapies
Future Treatment Options for Managing Primary Sclerosing Cholangitis and
Cholestatic Pruritus
